Cost-Effectiveness Colors ACIP Decision On Hep B Vaccination For Diabetics

The Centers for Disease Control’s Advisory Committee on Immunization Practices limited its Oct. 25 recommendation for vaccinating adult diabetics against hepatitis B to those under 60 years of age because of cost effectiveness considerations.